Episode
Side Table: The 340B Dilemma: Who Really Benefits?
- Podcast
- The Doctor's Lounge
- Published
- Nov 4, 2025
- Duration seconds
- 1796
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-doctor-s-lounge-7442524/episodes/side-table-the-340b-dilemma-who-really-benefits/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-doctor-s-lounge-7442524/side-table-the-340b-dilemma-who-really-benefits.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Send us a text 📌 Why Listen Explore the complexities of the 340B program, its impact on healthcare systems, and the implications for both hospitals and independent clinicians. Understand the need for transparency and potential reforms to align the program with its original goals. 👥 Co-Hosts Anthony DiGiorgio, DO, MHA – Neurosurgeon, UCSF; health policy researcher Anish Koka, MD – Cardiologist, Philadelphia; healthcare policy commentator 📌 Episode Overview In this episode, the hosts delve into the complexities of the 340B program, exploring its origins, current state, and the implications for hospitals and independent clinicians. They discuss how the program, initially intended to support hospitals serving low-income patients, has evolved into a significant revenue stream for large health systems, often at the expense of independent practices and without clear benefits to the intended beneficiaries. The conversation also touches on potential reforms and the need for greater transparency and accountability. Episode Links https://www.healthaffairs.org/content/forefront/340b-drug-pricing-program-capped-safety-net-grant https://jamanetwork.com/journals/jama-health-forum/fullarticle/2821579 💬 Notable Quotes "340B was created to help hospitals serving low-income patients." "The program has expanded to include 60,000 sites." "Hospitals can profit by reselling discounted drugs." "Independent clinicians face competitive disadvantages." "340B funds are not always used for patient care." 📚 What You’ll Learn The origins and current state of the 340B program. How hospitals leverage the program for revenue. The competitive disadvantages faced by independent clinicians. The lack of transparency in fund usage. Potential reforms to align the program with its original goals. ⏱ The Episod…